1. AB1149 Cystic fibrosis and inflammatory arthritis requiring immunosuppression: a worrying combination?. (12th June 2018) Authors: Ibrahim, M.E.T.; Clarke, E.; Martin, K.; Peckham, D.; Jones, A.; Horsley, A.; Watson, P.; Freeston, J.E. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Detection of drug‐responsive B lymphocytes and antidrug IgG in patients with β‐lactam hypersensitivity. Issue 6 (8th December 2016) Authors: Amali, M. O.; Sullivan, A.; Jenkins, R. E.; Farrell, J.; Meng, X.; Faulkner, L.; Whitaker, P.; Peckham, D.; Park, B. K.; Naisbitt, D. J. Journal: Allergy Issue: Volume 72:Issue 6(2017:Jun.) Page Start: 896 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Emergency treatment against a patient's wishes. Issue 6851 (22nd August 1992) Authors: Peckham, D. Journal: BMJ Issue: Volume 305:Issue 6851(1992) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HLA‐DQ allele‐restricted activation of nitroso sulfamethoxazole‐specific CD4‐positive T lymphocytes from patients with cystic fibrosis. Issue 8 (August 2015) Authors: Ogese, M. O.; Saide, K.; Faulkner, L.; Whitaker, P.; Peckham, D.; Alfirevic, A.; Baker, D. M.; Sette, A.; Pirmohamed, M.; Park, B. K.; Naisbitt, D. J. Journal: Clinical & experimental allergy Issue: Volume 45:Issue 8(2015:Aug.) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre. (June 2018) Authors: Spoletini, G.; Kennedy, M.; Flint, L.; Graham, T.; Etherington, C.; Shaw, N.; Whitaker, P.; Denton, M.; Clifton, I.; Peckham, D. Journal: Pulmonary pharmacology & therapeutics Issue: Volume 50(2018) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0285 Dalazatide, An Inhibitor of The Kv1.3 Channel on Activated Effector Memory T Cells, Has Immunotherapy Potential in Systemic Lupus Erythematosus. (15th July 2016) Authors: Stevens, A.M.; Yuasa, M.; Peckham, D.; Olsen, C.; Iadonato, S.P.; Probst, P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗